|
127 Companies |
|
139 Products |
|
139 Products |
|
89 Mechanisms of Action |
|
9 Trials |
|
1220 News |
|
| «12...1011121314151617181920...2425» |
- | pantoprazole / Generic mfg.
Trial completion: Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage (clinicaltrials.gov) - Feb 22, 2014
P2, N=12, Completed, Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Recruiting --> Completed
- | cisplatin / Generic mfg., paclitaxel / Generic mfg., irinotecan / Generic mfg.
Trial completion, Surgery: Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=97, Completed, Sponsor: Eastern Cooperative Oncology Group
Recruiting --> Completed Active, not recruiting --> Completed
- | erlotinib / Generic mfg.
Trial completion, Metastases: SWOG-S0127: Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: Southwest Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Herceptin (trastuzumab) / Roche
Trial completion: Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors (clinicaltrials.gov) - Feb 22, 2014
P1, N=18, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap
Trial completion, Metastases: Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer (clinicaltrials.gov) - Feb 22, 2014
P1, N=48, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Suspended --> Completed
- exatecan mesylate (DX-8951f) / Daiichi Sankyo
Trial completion, Metastases: DX-8951f in Treating Patients With Metastatic Stomach Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Daiichi Sankyo Inc.
Suspended --> Completed Suspended --> Completed
- | 5-fluorouracil / Generic mfg., paclitaxel / Generic mfg.
Trial completion: Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Radiation Therapy Oncology Group
Suspended --> Completed No longer recruiting --> Completed
- | paclitaxel / Generic mfg.
Trial completion, Metastases: Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=37, Completed, Sponsor: M.D. Anderson Cancer Center
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Surgery, Metastases: Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | carboplatin / Generic mfg., cisplatin / Generic mfg., floxuridine / Generic mfg.
Trial completion: Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=45, Completed, Sponsor: New York University School of Medicine
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=0, Completed, Sponsor: Northwestern University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction (clinicaltrials.gov) - Feb 19, 2014
P1/2, N=0, Completed, Sponsor: Northwestern University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | uridine triacetate (PN 401) / Wellstat
Trial completion, Metastases: S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach (clinicaltrials.gov) - Feb 19, 2014
P2, N=65, Completed, Sponsor: Southwest Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | cisplatin / Generic mfg., irinotecan / Generic mfg.
Trial completion, Surgery, Metastases: Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: New York University School of Medicine
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Herceptin (trastuzumab) / Roche
Trial completion: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (clinicaltrials.gov) - Feb 19, 2014
P1, N=15, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | tanespimycin (BMS-722782) / BMS, NN1213 / Novo Nordisk
Trial completion, Metastases: Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Not yet recruiting --> Completed
- | oxaliplatin / Generic mfg., irinotecan / Generic mfg.
Trial completion, Metastases: Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=36, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Not yet recruiting --> Completed Active, not recruiting --> Completed
- | cisplatin / Generic mfg., paclitaxel / Generic mfg.
Trial completion, Surgery: Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach (clinicaltrials.gov) - Feb 19, 2014
P2, N=55, Completed, Sponsor: Eastern Cooperative Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Leukine (sargramostim) / Partner Therap
Trial completion, Metastases: Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors (clinicaltrials.gov) - Feb 19, 2014
P2, N=24, Completed, Sponsor: Georgetown University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Interleukin-12 in Treating Patients With Cancer in the Abdomen (clinicaltrials.gov) - Feb 19, 2014
P1, N=29, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Surgery: Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=50, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- famotidine / Generic mfg., celecoxib oral / Generic mfg.
Trial suspension: Effect of Selective COX-2 Inhibition on Ulcer Healing (clinicaltrials.gov) - Feb 17, 2014
P3, N=200, Suspended, Sponsor: Chinese University of Hong Kong
Active, not recruiting --> Completed Recruiting --> Suspended
- | esomeprazole / Generic mfg.
Enrollment closed: IOE: Effect of IV and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic Therapy (clinicaltrials.gov) - Feb 17, 2014
P3, N=406, Active, not recruiting, Sponsor: Chinese University of Hong Kong
Recruiting --> Suspended Recruiting --> Active, not recruiting
- Enrollment open: Role of Statin on the Gastric Inflammation in Patients at High Risk of Gastric Cancer (clinicaltrials.gov) - Feb 16, 2014
P=N/A, N=55, Recruiting, Sponsor: Yonsei University
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- || Trial initiation date: HALT: Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding (clinicaltrials.gov) - Feb 11, 2014
P=N/A, N=80, Recruiting, Sponsor: Cook
Not yet recruiting --> Recruiting Initiation date: May 2011 --> Dec 2011
- || Enrollment change: HALT: Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding (clinicaltrials.gov) - Feb 11, 2014
P=N/A, N=80, Recruiting, Sponsor: Cook
Initiation date: May 2011 --> Dec 2011 N=30 --> 80
- ||| Enrollment open: HALT: Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding (clinicaltrials.gov) - Feb 11, 2014
P=N/A, N=80, Recruiting, Sponsor: Cook
N=30 --> 80 Completed --> Recruiting
- Erbitux (cetuximab) / Eli Lilly
Enrollment change, Metastases: Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer (clinicaltrials.gov) - Feb 9, 2014
P1/2, N=43, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Completed --> Recruiting N=55 --> 43
- | New P4 trial: Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm (clinicaltrials.gov) - Feb 9, 2014
P4, N=96, Recruiting, Sponsor: Wang Hua
- | Voquezna (vonoprazan) / Takeda, Phathom Pharma
Enrollment change: A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy (clinicaltrials.gov) - Feb 6, 2014
P3, N=27, Completed, Sponsor: Takeda
N=55 --> 43 N=160 --> 27
- | Voquezna (vonoprazan) / Takeda, Phathom Pharma
Enrollment change: A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy (clinicaltrials.gov) - Feb 6, 2014
P3, N=30, Completed, Sponsor: Takeda
N=160 --> 27 N=175 --> 30
- || Voquezna (vonoprazan) / Takeda, Phathom Pharma
Trial completion: A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy (clinicaltrials.gov) - Feb 6, 2014
P3, N=27, Completed, Sponsor: Takeda
N=175 --> 30 Recruiting --> Completed
- || Voquezna (vonoprazan) / Takeda, Phathom Pharma
Trial completion: A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy (clinicaltrials.gov) - Feb 6, 2014
P3, N=30, Completed, Sponsor: Takeda
Recruiting --> Completed Recruiting --> Completed
- haloperidol / Generic mfg.
New P4 trial: HATGAS: Haloperidol vs Conventional Therapy for Gastroparesis (clinicaltrials.gov) - Feb 5, 2014
P4, N=36, Recruiting, Sponsor: The University of Texas Health Science Center, Houston
- pemetrexed / Generic mfg., docetaxel / Generic mfg.
Enrollment closed, Combination therapy, Metastases: Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors (clinicaltrials.gov) - Feb 5, 2014
P1, N=54, Active, not recruiting, Sponsor: University of Arizona
Recruiting --> Completed Recruiting --> Active, not recruiting
- dexmedetomidine / Generic mfg.
Clinical: Comparative Study on the Effects of Epidural Dexmedetomidine on Heart Rate Variability During General Anesthesia in Patients Undergoing Gastrectomy (clinicaltrials.gov) - Feb 3, 2014
P=N/A, N=38, Completed, Sponsor: Yonsei University
Recruiting --> Active, not recruiting Recruiting --> Completed
- oxaliplatin / Generic mfg., leucovorin calcium / Generic mfg., everolimus / Generic mfg.
Enrollment closed, Metastases: Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer (clinicaltrials.gov) - Jan 28, 2014
P1/2, N=44, Active, not recruiting, Sponsor: City of Hope Medical Center
Recruiting --> Completed Recruiting --> Active, not recruiting
- | Avastin (bevacizumab) / Roche
New P1/2 trial, Circulating tumor cells, Tumor cell, Metastases: Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell (clinicaltrials.gov) - Jan 27, 2014
P1/2, N=86, Completed, Sponsor: Chinese PLA General Hospital
- remifentanil / Generic mfg., midazolam hydrochloride / Generic mfg.
Trial completion: Performance of Endoscopic Submucosal Dissection According to the Sedation Method (clinicaltrials.gov) - Jan 27, 2014
P=N/A, N=157, Completed, Sponsor: Yonsei University
Recruiting --> Active, not recruiting Recruiting --> Completed
- sorafenib / Generic mfg.
Trial completion: Sorafenib. ICORG 06-41, V4 (clinicaltrials.gov) - Jan 21, 2014
P2, N=54, Completed, Sponsor: ICORG- All Ireland Cooperative Oncology Research Group
Recruiting --> Completed Active, not recruiting --> Completed
- golvatinib (E7050) / Eisai
Enrollment change: A Phase I Study of E7050 in Subjects With Solid Tumors (clinicaltrials.gov) - Jan 20, 2014
P1, N=18, Completed, Sponsor: Eisai Co., Ltd.
Active, not recruiting --> Completed N=33 --> 18
- ||||| Enrollment closed: Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study) (clinicaltrials.gov) - Jan 20, 2014
P2/3, N=328, Active, not recruiting, Sponsor: Eisai Limited
N=33 --> 18 Recruiting --> Active, not recruiting
- | golvatinib (E7050) / Eisai
Trial completion: A Phase I Study of E7050 in Subjects With Solid Tumors (clinicaltrials.gov) - Jan 20, 2014
P1, N=18, Completed, Sponsor: Eisai Co., Ltd.
Recruiting --> Active, not recruiting Recruiting --> Completed
- clindamycin phosphate / Generic mfg.
Enrollment change: Additive Effect of Endonase on Eradication Rate of First Line Therapy for Helicobacter Pylori (clinicaltrials.gov) - Jan 19, 2014
P=N/A, N=112, Completed, Sponsor: Chuncheon Sacred Heart Hospital
Recruiting --> Completed N=216 --> 112
- | Panhematin (hemin) / Lundbeck, Recordati
Enrollment closed, IO biomarker: A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus) (clinicaltrials.gov) - Jan 19, 2014
P2, N=20, Active, not recruiting, Sponsor: Mayo Clinic
N=216 --> 112 Recruiting --> Active, not recruiting
- clindamycin phosphate / Generic mfg.
Trial completion: Additive Effect of Endonase on Eradication Rate of First Line Therapy for Helicobacter Pylori (clinicaltrials.gov) - Jan 19, 2014
P=N/A, N=112, Completed, Sponsor: Chuncheon Sacred Heart Hospital
Recruiting --> Active, not recruiting Recruiting --> Completed
- | New P2 trial: The Size of the Gastric Remnant as Determinant for Delayed Gastric Emptying After Whipple Resection. (clinicaltrials.gov) - Jan 16, 2014
P2, N=120, Enrolling by invitation, Sponsor: Karolinska University Hospital
- ||| Trial completion, HEOR: Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia (clinicaltrials.gov) - Jan 16, 2014
P=N/A, N=1264, Completed, Sponsor: Amgen
Recruiting --> Completed Active, not recruiting --> Completed
- ||| Carafate (sucralfate) / AbbVie
Enrollment change: A Study to Evaluate the Efficacy of Teprenone On Chinese Patients With Chronic Non-Atrophic Erosive Gastritis (clinicaltrials.gov) - Jan 12, 2014
P4, N=156, Completed, Sponsor: Changhai Hospital
Active, not recruiting --> Completed N=332 --> 156
- ||| onartuzumab (RG3638) / Roche
Enrollment closed, Combination therapy, Metastases: A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal Cancer (clinicaltrials.gov) - Jan 12, 2014
P2, N=123, Active, not recruiting, Sponsor: Hoffmann-La Roche
N=332 --> 156 Recruiting --> Active, not recruiting